Dr. Sheela C. Toprani, MD, PhD

Dr. Toprani practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Toprani's NPI, 1912311861, was assigned on June 18, 2014. Dr. Toprani graduated from Cleveland Medical College, Homeopathic in 2014. Dr. Toprani holds California license A163110.

Dr. Toprani's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Toprani's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Toprani to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toprani practices, 2 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Toprani's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Toprani is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Toprani is licensed in California.

Dmand AI lists epilepsy among the conditions Dr. Toprani treats.

CMS data shows 31 Medicare services from Dr. Toprani across 2 procedure codes in 2024, for 37 Medicare patients. Medicare paid $3,723 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Toprani in 2024. The largest group is under 65, with 13 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Toprani's median patient age at 50, with 47% women.

In 2024, Dr. Toprani wrote 174 Medicare Part D claims. 69% of them were for generic drugs. CMS names the drug for 125 of them, across 6 drugs with 11 or more claims each, at $32,098 in total drug cost. In 2023, CMS named 113 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Toprani for performance year 2024, reported as part of a group. Dr. Toprani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Toprani as offering telehealth.

Dmand AI links 4 papers to Dr. Toprani, published from 2022 to 2023. Dr. Toprani's most frequent co-authors are David M. Brandman, MD, Eyiyemisi Damisah and Lia Deleon Ernst, MD.

CMS Open Payments shows 4 general payments to Dr. Toprani from 3 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 60% of the total. Neuropace, Inc. paid the most, $354.

Dr. Toprani graduated from Cleveland Medical College, Homeopathic in 2014.

Dr. Toprani is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.